Home / Filers / OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM
institutional manager voting report
- Vote records reported
- 192year to 30 June 2025
- Against management
- 14.2%27 of 190 marked votes
- Say-on-pay support
- 85.6%for, of for + against + abstain
- Shareholder-proposal support
- not reportednot reported by managers
foragainstabstain, withhold or otheramber tick: the portion cast against management
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM reported 192 vote records for the year to 30 June 2025. It marked 14.2% of its votes as cast against management (27 of 190), 6.7 percentage points above the median institutional manager, which was 7.5%.
Weighted by the number of shares voted, the against-management share is 13.8%. The two figures differ when the votes against management fall on larger or smaller holdings than the rest.
On pay and on shareholder proposals: it voted for 85.6% of the section 14A say-on-pay items it reported (the median institutional manager: 91.3%).
By category, votes against management were most frequent in SECTION 14A SAY-ON-PAY VOTES (14.2% of 190).
Compared with other filers
Each rate is defined once, in the methodology. The median is taken over 2,562 institutional managers with at least 25 vote records in the season.
| year to 30 June 2025 | This filer | Median institutional manager | All filers pooled |
|---|---|---|---|
| Against-management share | 14.2% | 7.5% | 9.7% |
| Say-on-pay support rate | 85.6% | 91.3% | 84.3% |
| Shareholder-proposal support rate | not reported | 17.6% | 33.0% |
| Shares on loan, share of shares held | 0.00% | 0.00% | 2.20% |
| Largest families, year to 30 June 2026 | Against management | Say-on-pay support | Shareholder-proposal support |
|---|---|---|---|
| Vanguard | 20.1% | 94.1% | 42.0% |
| BlackRock and iShares | 7.5% | 88.3% | 11.9% |
| Fidelity | 6.0% | 94.7% | 27.6% |
| Dimensional | 16.4% | 78.9% | 57.4% |
| State Street and SPDR | 16.9% | 77.1% | 50.4% |
Of the 192 vote records in this filing, 193 carry something the form does not expect: a missing vote source or category, a record with no vote line, a meeting date that cannot be read, or a security identifier this site could not use. They are counted as filed. What is checked
Votes by category
Filers choose one or more categories for each vote, so a vote can appear in more than one row. Category names are printed as Form N-PX defines them.
| Category (as the form names it) | Votes | For | Against | Against management | Split |
|---|---|---|---|---|---|
| SECTION 14A SAY-ON-PAY VOTES | 191 | 149 | 25 | 14.2% |
By season
| Season | Vote records | Against management | Say-on-pay support | Shareholder-proposal support | Split |
|---|---|---|---|---|---|
| year to 30 June 2024 | 272 | 16.6% | 81.3% | not reported | |
| year to 30 June 2025 | 192 | 14.2% | 85.6% | not reported |
Say-on-pay votes against management
Counting one say-on-pay item per company meeting, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM voted against management on 24 of the 158 it marked either way (15.2%) in the year to 30 June 2025.
A further 1 say-on-pay item was reported without a management mark and are left out of both sides of that fraction.
- Amazon.com, Inc. 21 May 2025
- L3Harris Technologies, Inc. 18 Apr 2025
- Marathon Oil Corporation 29 Aug 2024
- Live Nation Entertainment, Inc. 12 Jun 2025
- Berry Global Group, Inc. 25 Feb 2025
- Intra-Cellular Therapies, Inc. 27 Mar 2025
- Ultragenyx Pharmaceutical Inc. 15 May 2025
- Peloton Interactive, Inc. 3 Dec 2024
- BridgeBio Pharma, Inc. 20 Jun 2025
- Sonos, Inc. 11 Mar 2025
- ADT Inc. 21 May 2025
- Viridian Therapeutics, Inc. 20 Jun 2025
- CommScope Holding Company, Inc. 8 May 2025
- SilverBow Resources, Inc. 29 Jul 2024
- Relay Therapeutics, Inc. 6 Jun 2025
- Praxis Precision Medicines, Inc. 26 Jun 2025
- UWM Holdings Corporation 4 Jun 2025
- AnaptysBio, Inc. 17 Jun 2025
- Ocular Therapeutix, Inc. 11 Jun 2025
- Altimmune, Inc. 26 Sep 2024
- Altice USA, Inc. 11 Jun 2025
- BeiGene, Ltd. 21 May 2025
- enVVeno Medical Corporation 18 Dec 2024
- VYNE Therapeutics Inc. 12 Dec 2024
Shareholder proposals it supported
Institutional managers report say-on-pay votes only, so no shareholder proposals appear here.
Shares on loan
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM reported no shares on loan for the year to 30 June 2025. Shares lent out at the record date cannot be voted by the lender, which is why Form N-PX asks for the figure. More on lending and votes.
The filings
These figures are read from the filer's own Form N-PX. If a vote on this page looks wrong, the filing is the record: a dispute about a filed vote is a matter for the filer, and an error in how this site read the filing is a matter for corrections.
- N-PX filed 21 Aug 2025 accession 0001132716-25-000025
- Every N-PX filing by this filer on EDGAR
Questions
How did OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM vote on executive pay?
In the year to 30 June 2025 OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM reported 174 votes in the category SECTION 14A SAY-ON-PAY VOTES that were cast for, against or abstain. 149 were for (85.6%), 25 against and 0 abstentions. Counting one item per company meeting, it voted against management on 24 of the 158 say-on-pay items it marked either way. A further 1 say-on-pay item was reported without a management mark and are not counted in that figure.
How often does OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM vote against management?
14.2% of the time in the year to 30 June 2025: 27 of the 190 votes it marked as for or against management. Form N-PX asks each filer to state, vote by vote, whether the vote was for or against management's recommendation; this figure counts those marks.
Is this the result of the meetings?
No. Form N-PX shows how this filer voted the shares it held. It does not show how other shareholders voted or whether a proposal was approved. Companies report certified results separately, on Form 8-K.
Where does the data come from?
From the Form N-PX filings of this filer on the SEC's EDGAR system, read as filed. The SEC does not verify the contents. Amended filings (N-PX/A) replace the filings they amend. Data on this page runs through 30 Sep 2026.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings by OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM (filer no. 1132716), read as filed and not verified by the SEC. Amended filings replace the filings they amend. Filings read through 30 Sep 2026; page built 1 Oct 2026.